Immutep reports strong response rate from immunotherapies treating carcinomas
Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JST | bye | 02/09/08 | 0 | 781 | |||
|
|||||||
JST | premier extends bid | 22/08/08 | 0 | 599 | |||
|
|||||||
JST | so will they get 90 percent by friday | 20/08/08 | 3 | 1.4K | |||
|
|||||||
JST | why the rise | 07/08/08 | 10 | 2.8K | |||
|
|||||||
JST | should i get on board | 06/08/08 | 1 | 875 | |||
|
|||||||
JST | looks cheap at 2.81 | 04/08/08 | 9 | 2.1K | |||
|
|||||||
JST | can someone please explain | 25/07/08 | 15 | 3.7K | |||
|
|||||||
JST | increased takeover offer | 24/07/08 | 5 | 1.6K | |||
|
See All Discussions